| Literature DB >> 21808264 |
Magdalena Hagn1, Kai Sontheimer, Karen Dahlke, Sabine Brueggemann, Christof Kaltenmeier, Thamara Beyer, Stefanie Hofmann, Oleg Lunov, Thomas F E Barth, Dorit Fabricius, Kyrylo Tron, Gerd Ulrich Nienhaus, Thomas Simmet, Hubert Schrezenmeier, Bernd Jahrsdörfer.
Abstract
Recently, CD4(+) T helper cells were shown to induce differentiation of human B cells into plasma cells by expressing interleukin (IL-)21 and CD40 ligand (CD40L). In the present study we show, that in the absence of CD40L, CD4(+) T cell-derived IL-21 induces differentiation of B cells into granzyme B (GzmB)-secreting cytotoxic cells. Using fluorescence-activated cell sorting (FACS) analysis, ELISpot and confocal microscopy, we demonstrate that CD4(+) T cells, activated via their T-cell receptor without co-stimulation, can produce IL-21, but do not express CD40L and rapidly induce GzmB in co-cultured B cells in an IL-21 receptor-dependent manner. Of note, we confirmed these results with recombinant reagents, highlighting that CD40L suppresses IL-21-induced GzmB induction in B cells in a dose-dependent manner. Surprisingly, although GzmB-secreting B cells did not express perforin, they were able to transfer active GzmB to tumor cell lines, thereby effectively inducing apoptosis. In contrast, no cytotoxic effects were found when effector B cells were activated with IL-2 instead of IL-21 or when target cells were cultured with IL-21 alone. Our findings suggest GzmB(+) cytotoxic B cells may have a role in early cellular immune responses including tumor immunosurveillance, before fully activated, antigen-specific cytotoxic T cells are on the spot. CD40 ligand determines whether IL-21 induces differentiation of B cells into plasma cells or into granzyme B-secreting cytotoxic cells.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21808264 DOI: 10.1038/icb.2011.64
Source DB: PubMed Journal: Immunol Cell Biol ISSN: 0818-9641 Impact factor: 5.126